Clinical Trial Update: Substance Misuse To Psychiatric Disorders for Cannabis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on a substance misuse to psychiatric disorders program focusing on cannabis use disorder with depressive/anxiety states.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Cannabis Use Disorder
• Major Depressive Disorder

Snippet

Sponsor: The University of Hong Kong | Conditions: Cannabis Use Disorder, Depressive State | Phase 2, Phase 3 | Status: COMPLETED